• CA-074 Me for Cathepsin B Pathway Assays

  2026-09-22

  CA-074 Me enables cell-permeable cathepsin B inhibition for separating lysosomal membrane permeabilization from downstream cell rupture. This practical guide combines live-cell imaging, dose design, and selectivity controls for necroptosis, apoptosis, and inflammation research.

• CA-074 Me: Cathepsin B Inhibitor Workflow

  2026-09-21

  CA-074 Me enables rapid, cell-permeable interrogation of cathepsin B during lysosomal membrane permeabilization, necroptosis, and related cell-death phenotypes. This workflow connects live-cell imaging, apoptosis assay design, biochemical validation, and inflammation research while highlighting controls for cathepsin L activity and compound handling.

• MLKL Polymerization Drives Lysosomal Permeabilization

  2026-09-21

  The reference study identifies lysosomal membrane permeabilization as a critical intermediate between MLKL polymerization and necroptotic plasma membrane rupture. Its imaging, induced-polymerization, pharmacological, and knockdown experiments position cathepsin B release as a major execution mechanism and provide a rationale for targeted lysosomal enzyme inhibition workflows.

• Danazol Research Workflows for Endocrine Models

  2026-09-20

  Build reproducible endocrine assays with Danazol by connecting steroidogenesis inhibition, androgen receptor signaling, and hypothalamic–pituitary–gonadal axis readouts. This practical guide translates a recent rat precocious-puberty model into cell, tissue, and translational workflows while emphasizing controls, formulation, and troubleshooting.

• EHEC Delays Precocious Puberty in Danazol Rat Models

  2026-09-19

  A 2025 study evaluated an Eclipta prostrata–Hordeum vulgare extract complex (EHEC) in rat models of precocious puberty induced by Danazol or a high-fat diet. EHEC delayed vaginal opening, reduced ovarian maturation, and attenuated hypothalamic GnRH mRNA elevation without changing body weight, supporting further investigation of hypothalamic–pituitary–gonadal axis modulation.

• CA-074 Me: Mapping Lysosomal Cell Death

  2026-09-18

  Learn how CA-074 Me, a membrane-permeable cathepsin B inhibitor, can help distinguish lysosomal membrane permeabilization from downstream cell death. This mechanistic guide connects inhibitor controls, orthogonal readouts, and TNF-driven disease models for more interpretable experiments.

• MLN4924 HCl Salt: From Neddylation to Viral Immunity

  2026-09-18

  Neddylation is more than a cancer biology endpoint: it is a control layer for protein stability, cell death, and host–pathogen interactions. This article explains how MLN4924 HCl salt can help translational researchers test the connection between NAE activity, SCF-dependent RIPK3 degradation, necroptosis, and inflammation while maintaining rigorous controls for pathway specificity and cell-cycle effects.

• Danazol in Endocrine Model Validation

  2026-09-17

  Danazol and Danocrine are valuable endocrine perturbation tools, but their strongest use comes from interpreting molecular, hormonal, and developmental endpoints together. This article explains how a recent rat study improves assay design and clarifies translational limits.

• One-step TUNEL Cy5 Kit: From Signal to Mechanism

  2026-09-17

  The One-step TUNEL Cy5 Apoptosis Detection Kit reveals DNA fragmentation while helping researchers distinguish an endpoint from its upstream cause. This article connects assay design with the IRG1–itaconic acid–TBK1 study and defines how TUNEL data can strengthen programmed cell death research.

• Antipyrine in BBB Permeability Workflows

  2026-09-16

  Antipyrine provides a practical, soluble comparator for linking barrier transport, recovery, and drug metabolism research in high-throughput CNS assays. This guide translates a validated LLC-PK1-MOCK/MDR1 workflow into actionable setup, normalization, troubleshooting, and optimization decisions.

• CD28–ARS2–PKM Splicing Supports CD8+ T Cells

  2026-09-16

  The reference study identifies a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM in activated CD8+ T cells. By favoring PKM2 over PKM1, this pathway supports flexible glucose use, interferon-γ production, and antitumor immunity independently of canonical CD28–PI3K signaling.

• Farnesyl Alcohol Azide for KRAS Studies

  2026-09-15

  Farnesyl Alcohol Azide offers a practical chemical handle for investigating how lipid modification influences KRAS localization, processing, and condensate behavior. This workflow combines probe validation, click-chemistry imaging, and orthogonal KRAS assays so researchers can distinguish true farnesylation-linked biology from nonspecific labeling.

• Triamcinolone B1859: Practical Protocol Guide

  2026-09-15

  Triamcinolone B1859 is a synthetic glucocorticoid agonist for controlled laboratory studies of glucocorticoid receptor signaling, inflammation, and immunosuppression. This guide addresses solvent selection, stock preparation, storage, controls, and assay QC; the material is for research use only and should not be used in diagnostic, therapeutic, or clinical workflows.

• Macrophage EV miR-660 Drives Breast Cancer Metastasis

  2026-09-14

  The reference study identifies a macrophage-to-tumor communication mechanism in which extracellular vesicles transfer miR-660 into breast cancer cells. By suppressing KLHL21 and releasing IKKβ/NF-κB p65 signaling, this cargo promotes invasion, migration, and metastatic spread, providing a mechanistic framework for studying tumor-associated macrophage biology.

• Pazopanib and ATRX-Deficient Glioma Vulnerability

  2026-09-14

  ATRX loss may expose a therapeutic dependency on receptor tyrosine kinase signaling in high-grade glioma. This thought-leadership article explains how Pazopanib (GW-786034) can be evaluated as a multi-targeted research tool, connects angiogenesis inhibition with tumor-cell signaling, and offers a biomarker-aware framework for combination studies with temozolomide.

8615 records 1/575 page Next 12345 下5页 Last page